Nautilus Biotechnology, Inc.
NAUT
$0.701
$0.03284.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.53% | 11.30% | -3.35% | -3.58% | -13.93% |
| Total Depreciation and Amortization | 2.25% | 2.14% | -2.33% | 8.70% | 9.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.72% | -31.15% | 36.10% | -0.69% | 9.43% |
| Change in Net Operating Assets | 24.74% | 61.34% | -74.78% | -513.41% | -4.11% |
| Cash from Operations | 13.63% | 14.32% | -2.94% | -11.71% | -14.08% |
| Capital Expenditure | 22.66% | 66.15% | -145.52% | 18.88% | -10.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.43% | -14.22% | 193.78% | -148.71% | 926.23% |
| Cash from Investing | 1.26% | -12.71% | 190.37% | -157.38% | 733.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -70.22% | -92.65% | 73.91% | 775.00% | 225.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -70.22% | -92.65% | 73.91% | 775.00% | 225.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 244.43% | -11.69% | 142.48% | -1,613.38% | 94.63% |